International Clinical Trial: A Single Dose, Randomized, Open-label, Two-way Crossover Food-effect Bioavailability Study of Fixed Dose Combination of Gemigliptin/ Dapagliflozin/Metformin 50/10/1000 mg Sustained Release Tablets under Fasting and Fed Conditions in Healthy Volunteers

Geneva, March 20 -- International Clinical Trials Registry received information related to the study (TCTR20260224004) titled 'A Single Dose, Randomized, Open-label, Two-way Crossover Food-effect Bioavailability Study of Fixed Dose Combination of Gemigliptin/ Dapagliflozin/Metformin 50/10/1000 mg Sustained Release Tablets under Fasting and Fed Conditions in Healthy Volunteers' on Feb. 24.

Study Type: Interventional

Study Design: Randomized

Primary Sponsor: International Bio Service Co., Ltd.

Condition: Bioequivalence study in healthy Thai volunteers Gemigliptin/Dapagliflozin/Metformin Bioequivalence study, Healthy Gemigliptin/Dapagliflozin/Metformin Bioequivalence study, Healthy

Intervention: Each tablet contains gemigliptin tart...